Evidence map›Paper›PMID 32879776›Full record

ArticleTranslational vision science & technology2020

Topical Corneal Cross-Linking Solution Delivered Via Corneal Reservoir in Dutch-Belted Rabbits.

Mariya Zyablitskaya, Charles Jayyosi, Anna Takaoka, Kristin M Myers, Leejee H Suh, Takayuki Nagasaki, Stephen L Trokel, David C Paik

Open access · goldAbstract read
In one paragraph

Article in Translational vision science & technology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Corneal stromal repair and regeneration.Progress in retinal and eye research · 2022
    Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Mariya ZyablitskayaDepartment of Ophthalmology, Columbia University, New York, NY, USA.
Charles JayyosiDepartment of Mechanical Engineering, Columbia University, New York, NY, USA.
Anna TakaokaDepartment of Ophthalmology, Columbia University, New York, NY, USA.
Kristin M MyersDepartment of Mechanical Engineering, Columbia University, New York, NY, USA.
Leejee H SuhDepartment of Ophthalmology, Columbia University, New York, NY, USA.
Takayuki NagasakiDepartment of Ophthalmology, Columbia University, New York, NY, USA.
Stephen L TrokelDepartment of Ophthalmology, Columbia University, New York, NY, USA.
David C PaikDepartment of Ophthalmology, Columbia University, New York, NY, USA.
Columbia University · US

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR024156 · NCRR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GINSBERG, HENRY N · 2006 to 2011
$53.0M
Instrumentation, Fabrication, and Design CoreP30EY019007 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Xin Zhang · 2010 to 2026
$12.9M
Therapeutic Corneal Cross-Linking Using Formaldehyde Releasing AgentsR01EY020495 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PAIK, DAVID C · 2011 to 2019
$3.6M
NCRR NIH HHS UL1 RR024156NEI NIH HHS P30 EY019007NEI NIH HHS R01 EY020495
6 · The paper itself

Abstract

Purpose: A topical corneal cross-linking solution that can be used as an adjunct or replacement to standard photochemical cross-linking (UV-riboflavin) methods remain an attractive possibility. Optimal concentration and delivery method for such topical corneal stabilization in the living rabbit eye were developed. Methods: A series of experiments were carried out using Dutch-belted rabbits (3 months old, weighing 1.0-1.5 kg) and topical cross-linking solutions (sodium hydroxymethylglycinate) (10-250 mM) delivered via corneal reservoir. The application regimen included a one-time 30-minute application (10-40 mM sodium hydroxymethylglycinate) as well as a once per week 5-minute application (250 mM sodium hydroxymethylglycinate) for 7 weeks. Animals were evaluated serially for changes in IOP, pachymetry, epithelial integrity, and endothelial cell counts. Keratocyte changes were identified using intravital laser scanning confocal microscopy. Post mortem efficacy was evaluated by mechanical inflation testing. Results: Overall, there were very few differences observed in right eye treated versus left eye controls with respect to intraocular pressure, pachymetry, and endothelial cell counts, although 30-minute cross-linking techniques did cause transient increases in thickness resolving within 7 days. Epithelial damage was noted in all of the 30-minute applications and fully resolved within 72 hours. Keratocyte changes were significant, showing a wound healing pattern similar to that after riboflavin UVA photochemical cross-linking in rabbits and humans. Surprisingly, post mortem inflation testing showed that the lower concentration of 20 mM delivered over 30 minutes showed the most profound stiffening/strengthening effect. Conclusions: Topical cross-linking conditions that are safe and can increase corneal stiffness/strength in the living rabbit eye have been identified. Translational Relevance: A topical corneal cross-linking solution delivered via corneal reservoir is shown to be both safe and effective at increasing tissue strength in living rabbit eyes and could now be tested in patients suffering from keratoconus and other conditions marked by corneal tissue weakness.

Indexed as

Corneal StromaPhotosensitizing AgentsAnimalsCollagenCross-Linking ReagentsHumansRabbitsUltraviolet RaysCollagenCross-Linking ReagentsPhotosensitizing Agentsbiomechanical inflation testingconfocal microscopycorneal cross-linkingcorneal reservoirkeratoconussodium hydroxymethylglycinate

Identifiers

PMID32879776
PMCPMC7442877
OpenAlexW3048890014

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.